Redirecting to http://smb.harlandaily.com/article/D3-Bio-Presents-KRAS-Pipeline-Updates-at-AACR-2026-Elisrasib-D3S-001-a-Next-Generation-KRAS-G12C-Inhibitor-Shows-Strong-Phase-2-Efficacy-Across-Multiple-Tumor-Types?storyId=69f2ca0d25e04a842cd6ae36